Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
USD 37.43
(6.82%)
USD 37.43
(6.82%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 608 Million JPY | 14.5% |
| 2022 | 531 Million JPY | 15.43% |
| 2021 | 460 Million JPY | -8.91% |
| 2020 | 505 Million JPY | -25.95% |
| 2019 | 682 Million JPY | 44.49% |
| 2018 | 472 Million JPY | -10.44% |
| 2017 | 527 Million JPY | -9.29% |
| 2016 | 581 Million JPY | -5.99% |
| 2015 | 618 Million JPY | 20.47% |
| 2014 | 513 Million JPY | -15.76% |
| 2013 | 609 Million JPY | 273.62% |
| 2012 | 163 Million JPY | -66.25% |
| 2011 | 483 Million JPY | -44.74% |
| 2010 | 874 Million JPY | -23.93% |
| 2009 | 1.14 Billion JPY | -31.81% |
| 2008 | 1.68 Billion JPY | 0.0% |
| 2007 | - JPY | -100.0% |
| 2006 | 207 Million JPY | -20.69% |
| 2005 | 261 Million JPY | -23.46% |
| 2004 | 341 Million JPY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 721 Million JPY | 0.0% |
| 2024 Q1 | 577 Million JPY | 0.0% |
| 2023 Q2 | 539 Million JPY | -2.18% |
| 2023 Q1 | 551 Million JPY | 3.77% |
| 2023 Q4 | 608 Million JPY | 14.07% |
| 2023 Q3 | 533 Million JPY | -1.11% |
| 2023 FY | 608 Million JPY | 14.5% |
| 2022 Q1 | 438 Million JPY | -4.78% |
| 2022 FY | 531 Million JPY | 15.43% |
| 2022 Q4 | 531 Million JPY | 42.36% |
| 2022 Q3 | 373 Million JPY | -9.25% |
| 2022 Q2 | 411 Million JPY | -6.16% |
| 2021 Q2 | 517 Million JPY | 15.92% |
| 2021 Q3 | 481 Million JPY | -6.96% |
| 2021 Q4 | 460 Million JPY | -4.37% |
| 2021 FY | 460 Million JPY | -8.91% |
| 2021 Q1 | 446 Million JPY | -11.68% |
| 2020 FY | 505 Million JPY | -25.95% |
| 2020 Q2 | 558 Million JPY | -6.69% |
| 2020 Q3 | 510 Million JPY | -8.6% |
| 2020 Q4 | 505 Million JPY | -0.98% |
| 2020 Q1 | 598 Million JPY | -12.32% |
| 2019 Q3 | 619 Million JPY | -4.48% |
| 2019 Q4 | 682 Million JPY | 10.18% |
| 2019 Q1 | 610 Million JPY | 29.24% |
| 2019 FY | 682 Million JPY | 44.49% |
| 2019 Q2 | 648 Million JPY | 6.23% |
| 2018 Q4 | 472 Million JPY | -3.08% |
| 2018 Q3 | 487 Million JPY | -2.4% |
| 2018 Q2 | 499 Million JPY | -2.54% |
| 2018 FY | 472 Million JPY | -10.44% |
| 2018 Q1 | 512 Million JPY | -2.85% |
| 2017 FY | 527 Million JPY | -9.29% |
| 2017 Q4 | 527 Million JPY | -2.41% |
| 2017 Q3 | 540 Million JPY | -2.53% |
| 2017 Q2 | 554 Million JPY | -2.29% |
| 2017 Q1 | 567 Million JPY | 0.0% |
| 2016 Q2 | 606 Million JPY | -1.94% |
| 2016 FY | 581 Million JPY | -5.99% |
| 2016 Q3 | 595 Million JPY | -1.82% |
| 2016 Q1 | 618 Million JPY | -1.44% |
| 2015 Q1 | 513 Million JPY | -3.57% |
| 2015 Q2 | 647 Million JPY | 26.12% |
| 2015 Q3 | 637 Million JPY | -1.55% |
| 2015 Q4 | 627 Million JPY | -1.57% |
| 2015 FY | 618 Million JPY | 20.47% |
| 2014 FY | 513 Million JPY | -15.76% |
| 2014 Q4 | 532 Million JPY | -3.45% |
| 2014 Q3 | 551 Million JPY | -4.01% |
| 2014 Q2 | 574 Million JPY | -5.75% |
| 2014 Q1 | 609 Million JPY | 521.43% |
| 2013 Q1 | 163 Million JPY | -19.31% |
| 2013 FY | 609 Million JPY | 273.62% |
| 2013 Q4 | 98 Million JPY | -19.01% |
| 2013 Q3 | 121 Million JPY | -8.33% |
| 2013 Q2 | 132 Million JPY | -19.02% |
| 2012 Q4 | 202 Million JPY | -22.31% |
| 2012 Q3 | 260 Million JPY | -20.73% |
| 2012 Q2 | 328 Million JPY | -32.09% |
| 2012 FY | 163 Million JPY | -66.25% |
| 2012 Q1 | 483 Million JPY | -16.29% |
| 2011 Q2 | 778 Million JPY | -10.98% |
| 2011 Q4 | 577 Million JPY | -14.77% |
| 2011 FY | 483 Million JPY | -44.74% |
| 2011 Q3 | 677 Million JPY | -12.98% |
| 2011 Q1 | 874 Million JPY | 0.0% |
| 2010 Q4 | - JPY | 0.0% |
| 2010 Q1 | 1.14 Billion JPY | 0.0% |
| 2010 Q3 | - JPY | 0.0% |
| 2010 FY | 874 Million JPY | -23.93% |
| 2010 Q2 | - JPY | -100.0% |
| 2009 Q1 | 1.68 Billion JPY | 0.0% |
| 2009 Q4 | - JPY | 0.0% |
| 2009 Q3 | - JPY | 0.0% |
| 2009 FY | 1.14 Billion JPY | -31.81% |
| 2008 FY | 1.68 Billion JPY | 0.0% |
| 2007 FY | - JPY | -100.0% |
| 2006 FY | 207 Million JPY | -20.69% |
| 2005 FY | 261 Million JPY | -23.46% |
| 2004 FY | 341 Million JPY | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | 24 Thousand USD | -2533233.333% |
| Bruush Oral Care Inc. | - USD | -Infinity% |
| CCA Industries, Inc. | - USD | -Infinity% |
| DSwiss, Inc. | 15.96 Thousand USD | -3808230.723% |
| EOS, Inc. | 66.58 Thousand USD | -913032.284% |
| Greyson International, Inc. | - USD | -Infinity% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | - USD | -Infinity% |
| Infusion Brands International, Inc. | 2.23 Million USD | -27142.755% |
| Mandom Corporation | - USD | -Infinity% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | - USD | -Infinity% |
| Oliveda International, Inc. | - USD | -Infinity% |
| PacificHealth Laboratories, Inc. | - USD | -Infinity% |
| Prosperous Future Holdings Limited | 6.33 Million USD | -9498.99% |
| PURE Bioscience, Inc. | 2.94 Million USD | -20517.158% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | 5.67 Million USD | -10616.479% |
| Sentient Brands Holdings Inc. | - USD | -Infinity% |
| Sunset Capital Assets, Inc. | - USD | -Infinity% |
| The Stephan Co. | 1.26 Million USD | -47887.372% |
| Turner Valley Oil & Gas, Inc. | - USD | -Infinity% |
| Winning Brands Corporation | 2.82 Million USD | -21385.671% |
| Warpaint London PLC | 4.19 Million USD | -14410.74% |
| Zoono Group Limited | 578.38 Thousand USD | -105019.565% |
| Zurvita Holdings, Inc. | - USD | -Infinity% |